|
AU6309698A
(en)
*
|
1997-03-12 |
1998-09-29 |
Banyu Pharmaceutical Co., Ltd. |
Drugs containing aminopyridine derivatives as the active ingredient
|
|
GB9709815D0
(en)
*
|
1997-05-14 |
1997-07-09 |
Merck Sharp & Dohme |
Therapeutic method
|
|
BR9810651A
(en)
*
|
1997-07-03 |
2000-10-03 |
Neurogen Corp |
Certain diarylimidazole derivatives; a new class of specific npy binders
|
|
ATE345330T1
(en)
*
|
1997-08-25 |
2006-12-15 |
Bayer Corp |
HETEROCYCLIC KETONES AS NPY Y5 ANTAGONISTS
|
|
WO1999027965A1
(en)
*
|
1997-11-28 |
1999-06-10 |
Banyu Pharmaceutical Co., Ltd. |
Antihyperlipemic agents
|
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
ID26128A
(en)
*
|
1998-04-29 |
2000-11-23 |
Ortho Mcneil Pharm Inc |
COMPOUNDS OF N-SUBSTITUTED N-AMINOTETRAL COMPOUNDS AS LIGANS FOR Y Y5 NEUPEPTIDE RECEPTORS WHICH ARE BENEFITABLE IN TREATMENT OF OBESITY AND OTHER INTERRUPTIONS
|
|
ATE314371T1
(en)
|
1998-11-10 |
2006-01-15 |
Merck & Co Inc |
SPIRO-INDOLE AS Y5 RECEPTOR ANTAGONISTS
|
|
US6407120B1
(en)
|
1999-02-18 |
2002-06-18 |
Pfizer Inc. |
Neuropeptide Y antagonists
|
|
AU3840000A
(en)
|
1999-04-20 |
2000-11-02 |
Meiji Seika Kaisha Ltd. |
Tricyclic compounds
|
|
US6218408B1
(en)
|
1999-06-30 |
2001-04-17 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (bicyclics)
|
|
US6989379B1
(en)
|
1999-04-22 |
2006-01-24 |
H. Lundbick A/S |
Selective NPY (Y5) antagonists
|
|
DE60034783T2
(en)
*
|
1999-04-22 |
2008-01-31 |
H. Lundbeck A/S, Valby |
SELECTIVE NPY (Y5) ANTAGONISTS
|
|
US6340683B1
(en)
|
1999-04-22 |
2002-01-22 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (triazines)
|
|
US6841552B1
(en)
|
1999-05-05 |
2005-01-11 |
Ortho-Mcneil Pharmaceutical, Inc. |
3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptide Y receptors ligands useful in the treatment of obesity and other disorders
|
|
CA2373035A1
(en)
*
|
1999-05-05 |
2000-11-16 |
Scott Dax |
3a,4,5,9b-tetrahydro-1h-benz[e]indol-2-yl amine-derived neuropeptide y receptors ligands useful in the treatment of obesity and other disorders
|
|
US6214853B1
(en)
|
1999-06-30 |
2001-04-10 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (bicyclics)
|
|
US6222040B1
(en)
|
1999-06-30 |
2001-04-24 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (tricyclics)
|
|
US7273880B2
(en)
|
1999-06-30 |
2007-09-25 |
H. Lunbeck A/S |
Selective NPY (Y5) antagonists
|
|
US6225330B1
(en)
|
1999-06-30 |
2001-05-01 |
Synaptic Pharmaceutical Corporation |
Selective NPY (Y5) antagonists (tricyclics)
|
|
AU1201401A
(en)
|
1999-10-15 |
2001-04-30 |
Du Pont Pharmaceuticals Company |
Benzylcycloalkyl amines as modulators of chemokine receptor activity
|
|
US6291499B1
(en)
*
|
1999-10-29 |
2001-09-18 |
Merck & Co., Inc. |
2-cyclohexyl benzimidazole NMDA/NR2B antagonists
|
|
SI1249233T1
(en)
|
1999-11-26 |
2009-02-28 |
Shionogi & Co |
Npyy5 antagonists
|
|
CN1441800A
(en)
|
2000-07-13 |
2003-09-10 |
伊莱利利公司 |
beta3 adrenergic agonists
|
|
KR20040058191A
(en)
*
|
2001-10-01 |
2004-07-03 |
다이쇼 세이야꾸 가부시끼가이샤 |
MCH Receptor Antagonists
|
|
CA2403307A1
(en)
|
2001-10-23 |
2003-04-23 |
Neurogen Corporation |
Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
|
|
ES2193875B2
(en)
|
2002-04-09 |
2005-03-01 |
Laboratorios Del Dr. Esteve, S.A. |
DERIVATIVES OF BENZOXAZINONA, ITS PREPARATION AND ITS APPLICATION AS MEDICATIONS.
|
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
|
EP1407774A1
(en)
*
|
2002-09-10 |
2004-04-14 |
LION Bioscience AG |
2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds
|
|
EP1398032A1
(en)
*
|
2002-09-10 |
2004-03-17 |
PheneX Pharmaceuticals AG |
4-Oxo-quinazolines as LXR nuclear receptor binding compounds
|
|
AU2003297048A1
(en)
|
2002-12-13 |
2004-07-09 |
Smithkline Beecham Corporation |
Cyclohexyl compounds as ccr5 antagonists
|
|
US20040192583A1
(en)
*
|
2002-12-19 |
2004-09-30 |
Satyanarayana Medicherla |
Treatment of obesity and associated conditions with TGF-beta inhibitors
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
JP2004315511A
(en)
*
|
2003-03-31 |
2004-11-11 |
Taisho Pharmaceut Co Ltd |
MCH receptor antagonist
|
|
US20070010671A1
(en)
*
|
2003-03-31 |
2007-01-11 |
Yoshinori Sekiguchi |
Novel quinazoline derivatives and methods of treatment related to the use thereof
|
|
ZA200508439B
(en)
|
2003-05-05 |
2007-03-28 |
Probiodrug Ag |
Medical use of inhibitors of glutaminyl and glutamate cyclases
|
|
WO2004111014A1
(en)
*
|
2003-06-06 |
2004-12-23 |
Vertex Pharmaceuticals Incorporated |
Pyrimidine derivatives as modulators of atp-binding cassette transporters
|
|
WO2006074147A2
(en)
|
2005-01-03 |
2006-07-13 |
Myriad Genetics, Inc. |
Nitrogen containing bicyclic compounds and therapeutical use thereof
|
|
JP5129957B2
(en)
|
2003-07-03 |
2013-01-30 |
ミリアド ジェネティクス， インコーポレイテッド |
4-Arylamino-quinazolines as caspase activators and inducers of apoptosis
|
|
US8309562B2
(en)
|
2003-07-03 |
2012-11-13 |
Myrexis, Inc. |
Compounds and therapeutical use thereof
|
|
ES2222833B1
(en)
|
2003-07-30 |
2006-03-01 |
Laboratorios Del Dr. Esteve, S.A. |
1,4-DISPOSED PIPERIDINIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICINES.
|
|
WO2005028438A1
(en)
|
2003-09-22 |
2005-03-31 |
Banyu Pharmaceutical Co., Ltd. |
Novel piperidine derivative
|
|
EP1723126A2
(en)
|
2003-10-22 |
2006-11-22 |
Eli Lilly And Company |
Novel mch receptor antagonists
|
|
NZ546887A
(en)
|
2003-11-03 |
2009-04-30 |
Probiodrug Ag |
Combinations useful for the treatment of neuronal disorders
|
|
GB0400193D0
(en)
*
|
2004-01-07 |
2004-02-11 |
Astrazeneca Ab |
Therapeutic agents
|
|
EP1713780B1
(en)
|
2004-02-05 |
2012-01-18 |
Probiodrug AG |
Novel inhibitors of glutaminyl cyclase
|
|
ZA200607639B
(en)
*
|
2004-03-30 |
2008-05-28 |
Taisho Pharmaceutical Co Ltd |
Pyrimidine derivatives and methods of treatment related to the use thereof
|
|
EP1734963A4
(en)
|
2004-04-02 |
2008-06-18 |
Merck & Co Inc |
METHOD FOR TREATING MEN WITH METABOLIC AND ANTHROPOMETRIC DISORDERS
|
|
JP2008505910A
(en)
*
|
2004-07-08 |
2008-02-28 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
Pyrimidine derivatives useful as inhibitors of PKC-theta
|
|
US8394765B2
(en)
|
2004-11-01 |
2013-03-12 |
Amylin Pharmaceuticals Llc |
Methods of treating obesity with two different anti-obesity agents
|
|
DK1814590T4
(en)
|
2004-11-01 |
2014-02-24 |
Amylin Pharmaceuticals Llc |
Treatment of obesity and related diseases.
|
|
US8258145B2
(en)
|
2005-01-03 |
2012-09-04 |
Myrexis, Inc. |
Method of treating brain cancer
|
|
US20090286723A1
(en)
|
2005-02-11 |
2009-11-19 |
Amylin Pharmaceuticals, Inc. |
Hybrid Polypeptides with Selectable Properties
|
|
US7737155B2
(en)
|
2005-05-17 |
2010-06-15 |
Schering Corporation |
Nitrogen-containing heterocyclic compounds and methods of use thereof
|
|
WO2006129826A1
(en)
|
2005-05-30 |
2006-12-07 |
Banyu Pharmaceutical Co., Ltd. |
Novel piperidine derivative
|
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
|
JP5118029B2
(en)
|
2005-06-14 |
2013-01-16 |
タイゲン バイオテクノロジー カンパニー，リミテッド |
Pyrimidine compounds
|
|
EP1916239A4
(en)
|
2005-08-10 |
2009-10-21 |
Banyu Pharma Co Ltd |
PYRIDONE COMPOUND
|
|
BRPI0614649A2
(en)
|
2005-08-11 |
2011-04-12 |
Amylin Pharmaceuticals Inc |
hybrid polypeptides with selectable properties
|
|
EP1921065B1
(en)
|
2005-08-24 |
2010-10-20 |
Banyu Pharmaceutical Co., Ltd. |
Phenylpyridone derivative
|
|
EP1939194A4
(en)
|
2005-09-07 |
2010-12-08 |
Banyu Pharma Co Ltd |
AROMATIC SUBSTITUTED BICYLIC PYRIDONE DERIVATIVE
|
|
AU2006297443B2
(en)
|
2005-09-29 |
2010-08-12 |
Merck Sharp & Dohme Corp. |
Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
|
|
KR20080059233A
(en)
|
2005-10-21 |
2008-06-26 |
노파르티스 아게 |
Renin inhibitors, and combinations of anti-dyslipidemics and / or anti-obesity agents
|
|
WO2007049798A1
(en)
|
2005-10-27 |
2007-05-03 |
Banyu Pharmaceutical Co., Ltd. |
Novel benzoxathiin derivative
|
|
ES2381205T3
(en)
|
2005-11-10 |
2012-05-24 |
Msd K.K. |
Aza-substituted spiro derivative
|
|
US9150507B2
(en)
|
2006-04-28 |
2015-10-06 |
Shionogi & Co., Ltd. |
Amine derivative having NPY Y5 receptor antagonistic activity
|
|
CA2770486C
(en)
|
2006-09-22 |
2014-07-15 |
Merck Sharp & Dohme Corp. |
Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer
|
|
WO2008038692A1
(en)
|
2006-09-28 |
2008-04-03 |
Banyu Pharmaceutical Co., Ltd. |
Diaryl ketimine derivative
|
|
JP5379692B2
(en)
|
2006-11-09 |
2013-12-25 |
プロビオドルグ エージー |
3-Hydroxy-1,5-dihydro-pyrrol-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcers, cancer and other diseases
|
|
WO2008065141A1
(en)
|
2006-11-30 |
2008-06-05 |
Probiodrug Ag |
Novel inhibitors of glutaminyl cyclase
|
|
ZA200905537B
(en)
|
2007-03-01 |
2010-10-27 |
Probiodrug Ag |
New use of glutaminyl cyclase inhibitors
|
|
JP5319518B2
(en)
|
2007-04-02 |
2013-10-16 |
Ｍｓｄ株式会社 |
Indoledione derivative
|
|
US9656991B2
(en)
|
2007-04-18 |
2017-05-23 |
Probiodrug Ag |
Inhibitors of glutaminyl cyclase
|
|
MX354786B
(en)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
USEFUL CYCLASS GUANILATE AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS.
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
SA08290668B1
(en)
|
2007-10-25 |
2012-02-12 |
شيونوجي آند كو.، ليمتد |
Amine Derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
|
|
PE20091309A1
(en)
*
|
2007-12-21 |
2009-09-30 |
Astrazeneca Ab |
CYCLOHEXYL DERIVATIVES AS ACETYL COENZYME CARBOXYLASE INHIBITORS
|
|
AU2009220605A1
(en)
|
2008-03-06 |
2009-09-11 |
Msd K.K. |
Alkylaminopyridine derivative
|
|
US20110015198A1
(en)
|
2008-03-28 |
2011-01-20 |
Banyu Pharmaceutical Co., Inc. |
Diarylmethylamide derivative having melanin-concentrating hormone receptor antagonism
|
|
CL2009000904A1
(en)
|
2008-04-21 |
2010-04-30 |
Shionogi & Co |
Compounds derived from cyclohexyl sulfonamides having antagonist activity at the npy y5 receptor, pharmaceutical composition and pharmaceutical formulation comprising them.
|
|
EA019289B1
(en)
|
2008-04-21 |
2014-02-28 |
Тайджен Байотекнолоджи Ко., Лтд. |
Aminopiridin, aminopirimidin and amino-1,3,5-triazine derivatives
|
|
CA2930674A1
(en)
|
2008-06-04 |
2009-12-10 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
EP2301936A1
(en)
|
2008-06-19 |
2011-03-30 |
Banyu Pharmaceutical Co., Ltd. |
Spirodiamine-diarylketoxime derivative
|
|
JP2011528375A
(en)
|
2008-07-16 |
2011-11-17 |
シナジー ファーマシューティカルズ インコーポレイテッド |
Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer, and other disorders
|
|
WO2010013595A1
(en)
|
2008-07-30 |
2010-02-04 |
萬有製薬株式会社 |
(5-membered)-(5-membered) or (5-membered)-(6-membered) fused ring cycloalkylamine derivative
|
|
AU2009307884B2
(en)
|
2008-10-22 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
EP2350010B1
(en)
|
2008-10-30 |
2014-03-26 |
Merck Sharp & Dohme Corp. |
Isonicotinamide orexin receptor antagonists
|
|
US8329914B2
(en)
|
2008-10-31 |
2012-12-11 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
WO2010056847A2
(en)
|
2008-11-13 |
2010-05-20 |
Taigen Biotechnology Co., Ltd. |
Lyophilization formulation
|
|
WO2010075068A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Pyridopyrimidine derivatives and methods of use thereof
|
|
WO2010075069A1
(en)
|
2008-12-16 |
2010-07-01 |
Schering Corporation |
Bicyclic pyranone derivatives as nicotinic acid receptor agonists
|
|
US8653125B2
(en)
|
2009-03-05 |
2014-02-18 |
Shionogi Co., Ltd. |
Cyclohexane derivative having NPY Y5 receptor antagonism
|
|
US8227618B2
(en)
|
2009-04-23 |
2012-07-24 |
Shionogi & Co., Ltd. |
Amine-derivatives having NPY Y5 receptor antagonistic activity and the uses thereof
|
|
PT2473487T
(en)
*
|
2009-09-03 |
2017-01-04 |
Bristol Myers Squibb Co |
Quinazolines as potassium ion channel inhibitors
|
|
EP2475428B1
(en)
|
2009-09-11 |
2015-07-01 |
Probiodrug AG |
Heterocylcic derivatives as inhibitors of glutaminyl cyclase
|
|
CA2786314A1
(en)
|
2010-02-25 |
2011-09-01 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
JP6026284B2
(en)
|
2010-03-03 |
2016-11-16 |
プロビオドルグ エージー |
Inhibitors of glutaminyl cyclase
|
|
NZ602312A
(en)
|
2010-03-10 |
2014-02-28 |
Probiodrug Ag |
Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
|
|
WO2011131748A2
(en)
|
2010-04-21 |
2011-10-27 |
Probiodrug Ag |
Novel inhibitors
|
|
JP5812500B2
(en)
|
2010-04-30 |
2015-11-17 |
メルク・シャープ・エンド・ドーム・コーポレイション |
Novel β3 adrenergic receptor agonist
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
BR122021002201A8
(en)
|
2011-02-25 |
2023-04-11 |
Merck Sharp & Dohme |
COMPOUND, COMPOSITION, USE OF A COMPOUND, AND METHOD OF TREATMENT OF A DISORDER, CONDITION OR DISEASE
|
|
JP6050264B2
(en)
|
2011-03-16 |
2016-12-21 |
プロビオドルグ エージー |
Benzimidazole derivatives as inhibitors of glutaminyl cyclase
|
|
AR088352A1
(en)
|
2011-10-19 |
2014-05-28 |
Merck Sharp & Dohme |
ANTAGONISTS OF THE RECEIVER OF 2-PIRIDILOXI-4-NITRILE OREXINE
|
|
AU2013296470B2
(en)
|
2012-08-02 |
2016-03-17 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
KR20150118158A
(en)
|
2013-02-22 |
2015-10-21 |
머크 샤프 앤드 돔 코포레이션 |
Antidiabetic bicyclic compounds
|
|
EP2970119B1
(en)
|
2013-03-14 |
2021-11-03 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
US9708367B2
(en)
|
2013-03-15 |
2017-07-18 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase and their uses
|
|
CA2905435A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
EP4424697A3
(en)
|
2013-06-05 |
2024-12-25 |
Bausch Health Ireland Limited |
Ultra-pure agonists of guanylate cyclase c, method of making and using same
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
CA2959208C
(en)
|
2014-08-29 |
2023-09-19 |
Tes Pharma S.R.L. |
Pyrimidine derivatives and their use as inhibitors of alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase
|
|
AU2017342083A1
(en)
|
2016-10-14 |
2019-04-11 |
Tes Pharma S.R.L. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
WO2018106518A1
(en)
|
2016-12-06 |
2018-06-14 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
EP3558298A4
(en)
|
2016-12-20 |
2020-08-05 |
Merck Sharp & Dohme Corp. |
ANTIDIABETIC SPIROCHROMAN COMPOUNDS
|
|
DK3461819T3
(en)
|
2017-09-29 |
2020-08-10 |
Probiodrug Ag |
GLUTAMINYL CYCLASE INHIBITORS
|
|
JP7638868B2
(en)
|
2018-11-20 |
2025-03-04 |
ティエエッセ ファルマ ソチエタ レスポンサビリタ リミタータ |
α-Amino-β-carboxymuconic acid semialdehyde decarboxylase inhibitors
|
|
AU2019387370A1
(en)
|
2018-11-30 |
2021-06-10 |
Nuvation Bio Inc. |
Pyrrole and pyrazole compounds and methods of use thereof
|
|
TW202045476A
(en)
|
2019-02-13 |
2020-12-16 |
美商默沙東藥廠 |
5-alkyl pyrrolidine orexin receptor agonists
|
|
EP3923933A4
(en)
|
2019-02-13 |
2022-08-17 |
Merck Sharp & Dohme Corp. |
PYRROLIDINE-LIKE OREXIN RECEPTOR AGONISTS
|
|
CN114340670A
(en)
|
2019-07-11 |
2022-04-12 |
普拉克西斯精密药物股份有限公司 |
Formulations of T-type calcium channel modulators and methods of use thereof
|
|
WO2021026047A1
(en)
|
2019-08-08 |
2021-02-11 |
Merck Sharp & Dohme Corp. |
Heteroaryl pyrrolidine and piperidine orexin receptor agonists
|
|
AU2021329805B2
(en)
|
2020-08-18 |
2024-02-29 |
Merck Sharp & Dohme Llc |
Bicycloheptane pyrrolidine orexin receptor agonists
|
|
CN114315802B
(en)
*
|
2021-12-14 |
2023-06-16 |
西安医学院 |
Quinazoline nitrogen-containing heterocyclic derivative, preparation method and application
|
|
KR102887982B1
(en)
*
|
2021-12-24 |
2025-11-25 |
아주대학교산학협력단 |
Novel compound for improving sleep and uses thereof
|